Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
Inflammatory processes are involved in the pathophysiology of both Alzheimer’s disease (AD) and multiple sclerosis (MS) but their exact contribution to disease progression remains to be deciphered. Biomarkers are needed to define pathophysiological processes of these disorders, who may increasingly...
Main Authors: | Joke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, Miguel D’haeseleer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1162340/full |
Similar Items
-
Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity
by: Joke Temmerman, et al.
Published: (2022-01-01) -
CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response
by: Lena Duchateau, et al.
Published: (2023-11-01) -
Cognitive Writing Process Characteristics in Alzheimer’s Disease
by: Catherine Meulemans, et al.
Published: (2022-07-01) -
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis
by: Stéphanie Hostenbach, et al.
Published: (2020-01-01) -
Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis
by: Wietse A. Wiels, et al.
Published: (2018-04-01)